ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance by enhancing MYH9-dependent degradation of GSK-3β and integrin β1-mediated phosphorylation of FAK
Li Cui(Qingdao University), Xinyuan Zhao(Southern Medical University)
Cited by 35
Related Papers
Targeting Squalene Epoxidase Confers Metabolic Vulnerability and Overcomes Chemoresistance in HNSCC
|Advanced Science|2023|30
FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1
|International Journal of Oral Science|2022|25